目的:对SSc骨溶解进行范围审查。
方法:本综述按照系统综述的首选报告项目和范围综述的Meta分析(PRISMA-ScR)推荐进行。
结果:在总共351个结果中,最终分析包括29篇文章。所包括的出版物在人群和纳入标准方面具有异质性。缺乏检测骨质溶解的标准化方法进一步加剧了这些不平等。大多数研究报告了骨溶解的位置/患病率以及与其他表现的关联。只有少数人专注于骨质溶解的预测因子及其预后价值。没有作者提到治疗方法。最常分析和最普遍的位置是肢端骨溶解(AO)。弥漫性皮肤亚型和抗拓扑异构酶I抗体与AO呈正相关。疾病持续时间,钙质沉着和数字缺血是更常见的与AO相关的特征,但只有最后2个预测AO。超声对AO的检测具有较高的灵敏度。
结论:尽管骨溶解对SSc患者有影响,这方面的研究明显缺乏。值得注意的是,没有专注于治疗的研究。此外,缺乏能够可靠评估其预后价值和预测因子的纵向研究.
To perform a scoping
review focusing on osteolysis in systemic sclerosis (SSc).
This
review was performed in line with the Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) recommendations.
From a total of 351 results, 29 articles were included for the final analysis. The publications included proved to be heterogeneous regarding the population and inclusion criteria. The lack of a standardized method of detection of osteolysis further enhanced these inequalities. Most studies reported location/prevalence of osteolysis and associations with other manifestations, with only a minority focusing on topics like predictors of osteolysis and its prognostic value. None of the authors addressed treatment approach. The most frequently analyzed and prevalent location was acro-osteolysis (AO). Diffuse cutaneous subtype and anti-topoisomerase I antibody correlated positively with AO. Disease duration, calcinosis, and digital ischemia were the features more frequently associated with AO, but only the last 2 predicted AO. Ultrasound showed high sensitivity for detection of AO.
Despite the effect that osteolysis has on patients with SSc, there is a significant lack of studies on this area. Notably, there are no studies that we know of focused on treatment. Also, there is a lack of longitudinal studies that would allow a reliable assessment of its prognostic value and predictors.